Compass Therapeutics Cash Flow Statement (2018-2026) | CMPX

Cash Flow Statement Jun2018 Sep2018 Dec2018 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-5.97M-12.98M-7.16M-8.49M-11.97M-11.59M-7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-13.46M-16.85M-16.63M-28.11M-27.37M-18.08M-53.21M-38.08M
Depreciation and Depletion (Quarter)
0.10M0.20M0.20M0.20M0.20M0.20M0.20M0.20M0.10M0.20M0.20M0.10M0.20M0.10M0.14M0.06M0.10M0.01M0.02M
Share-based Compensation (Quarter)
1.02M1.62M-4.36M-0.14M11.40M2.20M2.24M-0.81M19.50M2.20M7.55M5.07M45.80M
Cash from Operations (Quarter)
-3.46M-4.67M-7.94M-4.60M-10.94M-10.64M-12.23M-10.11M-5.92M-12.35M-13.89M-10.75M-11.05M-9.16M-13.21M-11.83M-10.85M-13.25M-17.27M-14.74M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.27M0.27M0.27M0.28M0.28M0.29M0.29M0.29M0.30M0.31M0.31M0.31M0.32M0.22M0.22M0.27M0.35M0.35M0.35M0.35M
Depreciation & Amortization (CF) (Quarter)
0.14M0.12M0.17M0.22M0.20M0.20M0.19M0.18M0.16M0.16M0.15M0.15M0.14M0.14M0.14M0.10M0.02M0.02M0.01M0.02M
Change in Working Capital
Change in Account Payables (Quarter)
0.31M-0.00M-0.61M6.20M-3.69M0.62M-2.26M-0.40M1.58M1.78M-3.24M0.34M-0.23M1.29M-0.67M1.02M0.50M-1.51M-0.68M2.00M
Change in Accured Expenses (Quarter)
0.82M6.59M-0.59M-5.39M2.95M5.95M-2.75M-1.12M-2.18M-3.13M-0.70M5.41M-4.31M3.37M6.93M-2.22M-2.31M2.70M-3.38M3.58M
Other Working Capital Changes (Quarter)
-0.25M-0.36M-0.27M-0.27M-0.28M-0.28M-0.29M-0.30M-0.30M-0.31M-0.32M-0.33M0.01M-0.58M-0.25M-0.04M-0.04M-0.04M-0.04M-0.16M
Investing Activities
Capital Expenditures (Quarter)
0.79M-0.60M0.19M-0.12M0.08M0.05M0.01M0.01M0.01M0.04M0.02M0.01M0.08M0.18M
Sales of Property, Plant and Equipment (Quarter)
0.00M0.00M0.17M
Change in Acquisitions & Divestments (Quarter)
12.76M36.20M59.19M37.39M34.43M51.40M37.78M37.55M34.41M25.23M36.44M26.81M13.93M24.10M83.33M35.81M
Cash from Investing Activities (Quarter)
-0.37M-0.78M-0.19M-105.54M1.18M-46.65M4.27M-0.67M17.05M6.31M-4.10M6.48M29.02M15.37M11.59M-6.36M-95.16M-3.38M38.43M-4.98M
Financing Activities
Other financing activities (Quarter)
0.01M0.01M0.04M0.02M3.85M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
1.88M3.75M
Change in Capital Stock
Shares Issued (Quarter)
3.66M0.00M5.60M5.38M3.23M3.58M7.88M4.45M11.33M13.62M14.06M7.38M8.34M17.16M16.35M8.17M23.65M
Net Equity Issued and Repurchased (Quarter)
128.00M76.24M3.10M0.03M18.10M0.01M138.00M
Misc.
Cash from Financing Activities (Quarter)
-1.88M124.24M0.01M75.75M0.04M3.03M0.02M-0.16M17.43M0.00M-0.00M-0.09M-0.81M129.36M1.06M3.37M
Change in Cash (Quarter)
-5.70M118.80M-8.13M-110.14M-9.76M18.46M-7.92M-7.75M11.15M-6.20M-0.55M-4.27M17.96M6.11M-2.44M-18.19M23.36M-15.57M24.52M-19.71M
Free Cash Flow (Quarter)
-4.25M-4.06M-8.14M-4.48M-11.02M-10.70M-12.23M-10.12M-5.93M-12.36M-13.89M-10.75M-11.10M-9.16M-13.23M-11.83M-10.86M-13.25M-17.35M-14.91M
Net Cash Flow (Quarter)
-5.70M118.80M-8.13M-110.14M-9.76M18.46M-7.92M-7.75M11.15M-6.20M-0.55M-4.27M17.96M6.11M-2.44M-18.19M23.36M-15.57M24.52M-19.71M